• Alphabet, Google's parent company, has requested U.S. Environmental Protection Agency (EPA) approval to release 32 million laboratory-bred male mosquitoes in California and Florida over a two-year period.
• The mosquitoes are infected with Wolbachia, a naturally occurring bacterium that prevents mosquito eggs from hatching after mating, helping reduce disease-carrying mosquito populations.
• The proposal is part of Alphabet's Debug project, which aims to curb mosquito-borne diseases such as dengue, Zika, chikungunya, West Nile virus, and St. Louis encephalitis.
Alphabet, the parent company of Google, is seeking approval from the U.S. Environmental Protection Agency (EPA) to release laboratory-bred male mosquitoes in California and Florida under its Debug program. The EPA is currently reviewing the application and has opened a public comment period before taking a final decision.
According to the proposal, up to 16 million male mosquitoes per year could be released in Florida and up to 16 million per year in California over a two-year period, allowing for the release of up to 64 million mosquitoes in total as part of a large-scale biological control effort aimed at reducing disease-carrying mosquito populations linked to illnesses such as dengue, Zika, and West Nile virus.¹
The initiative uses male mosquitoes infected with Wolbachia bacteria, a naturally occurring microorganism that prevents eggs from hatching when infected males mate with wild females. Since only female mosquitoes bite humans, the release of males is not expected to increase biting activity.
The EPA filing, cited in the review process, notes that the trial would take place across selected areas in California and Florida, though exact locations have not been disclosed. The proposal remains under regulatory assessment by the agency before any field release is approved.
The EPA application specifically involves Wolbachia-infected male Culex quinquefasciatus mosquitoes (DQB strain), a species associated with the transmission of West Nile virus and St. Louis encephalitis.¹
The Debug program under Alphabet’s life sciences division uses laboratory-bred male mosquitoes infected with Wolbachia bacteria to reduce disease-carrying mosquito populations.
When these modified males mate with wild female mosquitoes, the resulting eggs do not hatch. Over time, this interrupts reproduction cycles and gradually reduces the overall mosquito population in targeted areas.
Because only female mosquitoes bite and transmit diseases, the release of male mosquitoes does not increase the risk of human biting or disease spread.
The approach uses Wolbachia-induced reproductive incompatibility, a mosquito suppression strategy related to sterile insect control methods that has been used as an alternative to chemical insecticides in managing agricultural pests and disease vectors.²
Also see: Could Patchouli Oil Save Your Skin From Mosquito Bites?
Singapore's National Environment Agency (NEA) has previously reported reductions in Aedes aegypti mosquito populations and declines in dengue cases following large-scale releases of Wolbachia-carrying male mosquitoes under its own Project Wolbachia initiative.³
The Singapore experience has been widely cited as evidence supporting the potential effectiveness of Wolbachia-based mosquito control strategies.³
In the current proposal, the scope of mosquito control is widened to include Culex quinquefasciatus, a species associated with the transmission of West Nile virus and St. Louis encephalitis, marking a broader approach to mosquito-borne disease control under the EPA-reviewed initiative.
If approved, the program could offer new evidence on the effectiveness of Wolbachia-based mosquito control in reducing the spread of vector-borne diseases while decreasing reliance on chemical insecticides.
The U.S. Environmental Protection Agency (EPA) will determine whether Alphabet’s experimental mosquito release proceeds in California and Florida. The decision is expected to influence future mosquito-control approaches in regions affected by diseases such as dengue, Zika, and West Nile virus.
References:
U.S. Environmental Protection Agency. “EPA Grants Extension of Experimental Use Permit for Wolbachia Mosquito.” EPA News Releases, September 21, 2016. https://www.epa.gov/pesticides/epa-grants-extension-experimental-use-permit-wolbachia-mosquito.
U.S. Environmental Protection Agency. “Pesticide Experimental Use Permit; Receipt of Application; Comment Request.” Federal Register. Accessed June 2, 2026.
U.S. Environmental Protection Agency. “EPA Registers the Wolbachia ZAP Strain in Live Male Asian Tiger Mosquitoes.” November 3, 2017. https://www.epa.gov/pesticides/epa-registers-wolbachia-zap-strain-live-male-asian-tiger-mosquitoes
National Environment Agency (Singapore) Project Wolbachia. https://www.nea.gov.sg/corporate-functions/resources/research/project-wolbachia-singapore
(Rh/TP/MSM)